With one eye on the future.
Journal
Cancer cell
ISSN: 1878-3686
Titre abrégé: Cancer Cell
Pays: United States
ID NLM: 101130617
Informations de publication
Date de publication:
14 03 2022
14 03 2022
Historique:
entrez:
15
3
2022
pubmed:
16
3
2022
medline:
3
5
2022
Statut:
ppublish
Résumé
In the past 20 years we have seen the rise of a new era of cancer research that moved its focus away from the cancer cell itself and revealed a complexity of interactions, both within the tumor and with the host, that ultimately dictate the evolution and progression of the disease. We have witnessed the development of immunotherapies that changed the fate of many patients and new diagnostic strategies with the potential of changing clinical practice. In this article, several experts discuss what lies ahead.
Identifiants
pubmed: 35290781
pii: S1535-6108(22)00071-X
doi: 10.1016/j.ccell.2022.02.019
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
221-225Subventions
Organisme : Medical Research Council
ID : G0300648
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 16942
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 29911
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M009041/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 9675
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 16465
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 29567
Pays : United Kingdom
Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests A.M., C.E.B., C.C., N.D., J.H., P.L., K.P., M.R., S.T., and Z.Z. declare no competing interests.